HOSPITAL News & Analysis

Fisher & Paykel’s share price has soared as COVID-19 cases rise in Australia, US and Europe, while CSL’s latest acquisition marks...

Investors may have a small window of opportunity to reduce holdings in Healthscope ahead of the finalised acquisition by Canadian asset manager...

Australian hospital operator Healius has received a non-binding $2.02bn bid from a unit of its largest shareholder, China's Jangho Group, to buy it...

ASX-listed biotech giant CSL has exceeded its profit expectations, lifting its full-year net profit by 29 per cent to $US1.73 billion...

This ASX-listed biotech is working on a "blockbuster" cardiovascular product that has the potential to take its stock price to $250, says Morningstar...

The board of Australia’s second largest private hospital operator has rejected two takeover bids, saying both proposals undervalue the...

As the outsize segment of Australia's population aged 65 years and over expands, it's creating investment opportunities in several areas, but you...